Dr. David M. Schuster, MD

Claim this profile

Emory University Hospital/Winship Cancer Institute

Studies Stomach Cancer
Studies Prostate Cancer
2 reported clinical trials
6 drugs studied

Affiliated Hospitals

Image of trial facility.
Emory University Hospital/Winship Cancer Institute

Clinical Trials David M. Schuster, MD is currently running

Image of trial facility.

Radioligand + Radiation Therapy

for Prostate Cancer

This phase I trial tests the safety, side effects and best dose of radioligand therapy (lutetium Lu 177 PSMA-10.1 \[177Lu-rhPSMA-10.1\]) after prostate specific membrane antigen (PSMA) positron emission tomography (PET)-guided external beam radiotherapy in treating post-prostatectomy patients with prostate cancer that has come back after a period of improvement (recurrent). In this study, radioligand therapy is a radioactive drug called 177Lu-rhPSMA-10.1. It works by binding to PSMA-expressing prostate tumor cells and delivering the radioactive portion of the drug directly to the tumor cells while not harming normal cells. Radiation therapy such as external beam radiotherapy uses high energy x-rays to kill tumor cells and shrink tumors. Giving radioligand therapy with PSMA PET-guided external beam radiotherapy may kill more tumor cells in post-prostatectomy patients with biochemically recurrent prostate cancer.
Recruiting1 award Phase 1

More about David M. Schuster, MD

Clinical Trial Related1 year of experience running clinical trials · Led 2 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments David M. Schuster, MD has experience with
  • External Beam Radiation Therapy
  • Lutetium Lu 177 PSMA-10.1
  • Computed Tomography
  • Fluciclovine F18
  • Gallium Ga 68 Gozetotide
  • Positron Emission Tomography
Breakdown of trials David M. Schuster, MD has run
Stomach Cancer
Prostate Cancer
Prostate Adenocarcinoma
Breast Cancer
Breast cancer

Other Doctors you might be interested in

Melinda L. YushakEmory University Hospital/Winship Cancer Institute
Jennifer GrossEmory University Hospital/Winship Cancer Institute
Viraj Master, MD, PhDWinship Cancer Institute at Emory University

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David M. Schuster, MD specialize in?
David M. Schuster, MD focuses on Stomach Cancer and Prostate Cancer. In particular, much of their work with Stomach Cancer has involved treating patients, or patients who are undergoing treatment.
Is David M. Schuster, MD currently recruiting for clinical trials?
Yes, David M. Schuster, MD is currently recruiting for 1 clinical trial in Atlanta Georgia. If you're interested in participating, you should apply.
Are there any treatments that David M. Schuster, MD has studied deeply?
Yes, David M. Schuster, MD has studied treatments such as External Beam Radiation Therapy, Lutetium Lu 177 PSMA-10.1, Computed Tomography.
What is the best way to schedule an appointment with David M. Schuster, MD?
Apply for one of the trials that David M. Schuster, MD is conducting.
What is the office address of David M. Schuster, MD?
The office of David M. Schuster, MD is located at: Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia 30322 United States. This is the address for their practice at the Emory University Hospital/Winship Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top